# OnCo record paper-straughn-ivermectin-hope-versus-hype-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-straughn-ivermectin-hope-versus-hype-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-straughn-ivermectin-hope-versus-hype-2025" ;
  schema:name "Ivermectin treatment for gynecologic cancers: hope versus hype"@en ;
  schema:description "An editorial accompanying the gynaecological review: repurposing is legitimate and early trials deserve support, but no major oncology organisation endorses ivermectin for cancer and patients should not forgo proven treatment for it."@en ;
  schema:url <https://onco.cc/key-papers/paper-straughn-ivermectin-hope-versus-hype-2025/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.gore.2025.101920>, <https://pubmed.ncbi.nlm.nih.gov/40896730/> ;
  schema:sameAs <https://doi.org/10.1016/j.gore.2025.101920> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Straughn JM." ;
  onco:technologies <https://onco.cc/technologies/drug-repurposing/>, <https://onco.cc/technologies/fenbendazole-ivermectin-repurposing-claims/> ;
  onco:drugs <https://onco.cc/drugs/ivermectin/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-generic-repurposing/>, <https://onco.cc/bottlenecks/b-misinformation/> .